Top News
Elevance Health’s Anthem Blue Cross Blue Shield accuses physicians of falsifying patient medical records with the intention of getting the insurer to pay for improper prescribing of the diabetes drug Ozempic for weight…
Continue Reading
What You Should Know:
– A new study suggests that a weekly treatment with semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, may significantly reduce the risk of kidney failure and other complications in patients with…
Continue Reading
As the nation grapples with a GLP-1 shortage, Hims & Hers is looking to improve access by making compounded GLP-1s available on its platform starting at $199 a month, the company announced Monday.
The San…
Continue Reading
Direct-to-consumer virtual care company Hims & Hers is the latest digital health company to announce it will add GLP-1 medications to its offerings to assist users with weight loss management. The San Francisco-based company, which…
Continue Reading
New Jersey-based nutritional supplements supplier The Vitamin Shoppe announced its launching of Whole Health Rx, a telehealth service that will connect users with providers to help them access GLP-1 medications for weight management. GLP-1s, or…
Continue Reading
Guy Friedman, co-founder and CEO of SteadyMD
The past few years have seen upheavals in healthcare, and 2024 so far shows no signs of breaking that pattern.
While the fundamentals of healthcare remain the same –…
Continue Reading
Dr. Stephanie Teotia, a distinguished board-certified plastic and reconstructive surgeon from Flower Mound, TX who serves patients in the Dallas area joins eHealth Radio and the Plastic Surgery Information Channel.
In today’s episode, Dr. Teotia,…
According to the CDC, 42% of Americans are considered obese. There aren’t enough obesity medicine specialists to see them all. Brand medications are on the FDA shortage list and natural methods such as diet…
Continue Reading
GLP-1 medications like Ozempic and Wegovy remain in high demand and continue to make headlines, even among mainstream media outlets. As the healthcare industry watches closely to see how payers decide to cover the…
Continue Reading
GLP-1 medications like Ozempic, Wegovy, and Mounjaro have ushered in a new era for the weight loss market in 2024 and surfaced several questions that have been festering for quite some time and can…
Continue Reading
